Business
Press Release Dec 16 2022
Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 16-Dec-2022 titled Aurigene Oncology Limited,, a wholly owned subsidiary of the Company, reports results of AUR101 in Phase II Study in Patients with moderate to severe psoriasis
About this update from Dr. Reddy's Laboratories Ltd.
[{"type":"text","content":" Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 16-Dec-2022 titled Aurigene Oncology Limited,, a wholly owned subsidiary of the Company, reports results of AUR101 in Phase II Study in Patients with moderate to severe psoriasis View Attachment","length":415,"tagName":"div"}]